Haemophilia Trial, Recruiting NCT07723560 Sponsor: Hospices Civils de Lyon Condition: Haemophilia
Back to Haemophilia

Haemophilia Trial, Recruiting

NCT07723560
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have Hemophilia A
  • People who have had surgery performed using a medicine called Altuvoct®
  • People who have given their consent to take part after receiving detailed written information about the trial

Who may not be able to join:

  • People who have a blood clotting disorder other than Hemophilia A
  • People who have detectable inhibitors (antibodies that work against) Factor VIII
  • People who have a known serious liver condition
  • People who have a known serious kidney condition
  • People who have a known allergic reaction or sensitivity to Altuvoct® or any of its ingredients
  • People who are currently taking part in another clinical trial (note: being part of a non-interventional study, where no treatment is being tested, is not a reason for exclusion)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
3 January 2026
Est. completion
1 March 2026

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Perioperative Altuvoct® Utilization for Hemostatic Management

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov